LT
LifeMine Therapeutics
United States · Biotech · Healthtech
Develops fungal genome-derived therapeutics for organ transplant rejection
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series D+Series E | $263M | ARCH Venture Partners — Role not disclosedBezos Expeditions — Role not disclosedGates Frontier — Role not disclosedGSK — Role not disclosedGV (Google Ventures) — Role not disclosedInvus — Role not disclosedLoLa Capital Partners — Role not disclosedMilky Way Investments — Role not disclosedRA Capital Management — Role not disclosed |